Is it safe to take Calocurb along with other GLP-1 medications?

Is it safe to take Calocurb along with other GLP-1 medications?

Yes, it is safe to take Calocurb alongside other GLP-1 medications.  It can be even encouraged because you can potentially be on a a lower dosage of GLP-1 meds when combine with Calocurb.  Also it can be an option you might consider for a transition plan if you plan to stop taking GLP-1 medications.  You may consider training your body to handle cravings with Calocurb to help minimize rebound weight gain.
    • Related Articles

    • How do I take Calocurb?

      You can tailor your dosage daily, to take between 1-4 capsules. Day 1 - 2: Take one capsule one hour before a meal. Day 3 - 4: Take one capsule twice daily, one hour before meals. Day 5+: Take two capsules twice daily, one hour before meals. Max: ...
    • What ingredients are in Calocurb?

      Calocurb's active ingredient is Amarasate®, an extract from hops only grown in the South Island of New Zealand. Amarasate® works by stimulating the gastric tastebuds to release a natural blend of gastric peptides GLP-1, CCK, and PYY. This triggers ...
    • What are the potential side effects of Calocurb?

      In clinical studies, Calocurb showed a low incidence of side effects when starting on Calocurb, and no ongoing side effects . Mild patient discomfort (e.g., loose stools) can occur in the first 24–72 hours as your body adjusts to the levels of GLP-1 ...
    • What if I don't notice a difference when taking Calocurb?

      Everyone has a different physiological makeup, so some people will experience the biological affect of Amarasate® differently. If you are one of the few who have started taking Calocurb and are not seeing any difference in appetite simply try ...
    • What is Calocurb?

      Calocurb is a prescription-free dietary supplement made from Amarasate®, which comes from a specific variety of Hops grown in New Zealand and has been clinically proven to reduce hunger by 30%, reduce cravings by 40% and reduce calorie intake by 18%, ...